Production Method 1

501-30-4

79725-98-7

Reaction Conditions

1.1 Catalysts: Pyridine Solvents: Dimethylformamide ;  15 °C; 4 h, 15 - 25 °C; 1 h, rt; 12 h, rt

Reference

Synthesis of kojic dipalmitate

Shen, Xin-an, Huaxue Shiji, 2015, 37(5), 478-480

Production Method 2

57-10-3

79725-98-7

Reaction Conditions

1.1 Reagents: Thionyl chloride ;  5 h, 60 - 65 °C; 65 °C → 75 °C; 2 h, 75 °C
2.1 Catalysts: Pyridine Solvents: Dimethylformamide ;  15 °C; 4 h, 15 - 25 °C; 1 h, rt; 12 h, rt

Reference

Synthesis of kojic dipalmitate

Shen, Xin-an, Huaxue Shiji, 2015, 37(5), 478-480

Production Method 3

501-30-4

79725-98-7

Reaction Conditions

1.1 Solvents: Pyridine ;  20 °C; 20 °C → 30 °C; 2 h, 30 °C

Reference

Preparation of kojic dipalmitate

Zhaona, Si-tu; et al, Jingxi Yu Zhuanyong Huaxuepin, 2009, 17(18), 23-24

Production Method 4

501-30-4

57-10-3

79725-98-7

Reaction Conditions

1.1 Catalysts: Triacylglycerol lipase Solvents: Acetone ;  400 min, 50 °C

Reference

Double-lipase catalyzed synthesis of kojic dipalmitate in organic solvents

Wang, Zhiyuan; et al, Chemical Research in Chinese Universities, 2017, 33(6), 903-907

Production Method 5

57-10-3

79725-98-7

Reaction Conditions

1.1 Reagents: Triphosgene Solvents: Chlorobenzene ;  rt → 5 °C
1.2 Catalysts: Triethylamine ,  Imidazole Solvents: Chlorobenzene ;  1 h, < 5 °C; 1 h, rt
2.1 Solvents: Pyridine ;  20 °C; 20 °C → 30 °C; 2 h, 30 °C

Reference

Preparation of kojic dipalmitate

Zhaona, Si-tu; et al, Jingxi Yu Zhuanyong Huaxuepin, 2009, 17(18), 23-24

(4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate Raw materials

• Kojic acid
• Palmitic acid

(4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate Preparation Products

• (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate (79725-98-7)

• 1. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993

• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Introduction to (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate and CAS No. 79725-98-7

Compound with the CAS number 79725-98-7 and the product name (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate represents a significant advancement in the field of chemical and biomedical research. This compound, characterized by its unique structural and functional properties, has garnered considerable attention due to its potential applications in various therapeutic and pharmacological contexts.

The molecular structure of (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate consists of a pyran ring substituted with a palmitoyloxy group at the 5-position and a methyl palmitate moiety at the 2-position. This configuration imparts specific biochemical interactions that make it a promising candidate for further investigation in drug development. The presence of palmitoyl chains enhances the compound's solubility and stability, which are critical factors in pharmaceutical formulations.

In recent years, there has been a growing interest in exploring novel compounds that can modulate cellular processes and enhance therapeutic outcomes. The (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate has shown potential in preclinical studies as a modulator of lipid metabolism and signaling pathways. Its ability to interact with specific receptors and enzymes suggests that it could be utilized in the treatment of metabolic disorders, inflammation, and other chronic conditions.

One of the most compelling aspects of this compound is its structural similarity to naturally occurring bioactive molecules. This similarity allows it to mimic or enhance the effects of endogenous compounds, potentially leading to more effective therapeutic interventions. For instance, studies have indicated that derivatives of this compound may have anti-inflammatory properties by inhibiting key inflammatory pathways such as NF-κB and MAPK.

The synthesis of (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate involves a series of well-defined chemical reactions that highlight the expertise required in organic synthesis. The use of advanced techniques such as palladium-catalyzed cross-coupling reactions ensures high yields and purity, which are essential for pharmaceutical applications. The compound's stability under various conditions further underscores its suitability for industrial-scale production.

Current research is focused on understanding the mechanisms through which this compound exerts its biological effects. Preliminary studies have demonstrated its ability to interact with lipid rafts, which are critical components of cell membranes involved in signal transduction. By modulating lipid raft dynamics, this compound may influence a wide range of cellular processes, including neurotransmitter release and immune responses.

The potential applications of (4-Oxo-5-(palmitoyloxy)-4H-pyran-2-yl)methyl palmitate extend beyond traditional pharmaceuticals. Its unique properties make it an attractive candidate for use in cosmetic formulations, where it could contribute to skin health by enhancing barrier function and reducing inflammation. Additionally, its stability and compatibility with other ingredients suggest that it could be incorporated into topical treatments for various skin conditions.

In conclusion, the compound identified by CAS number 79725-98-7 represents a significant advancement in chemical and biomedical research. Its unique structure, combined with its demonstrated biological activity, makes it a promising candidate for further investigation and development. As research continues to uncover new applications and mechanisms of action, this compound is poised to play a crucial role in addressing some of the most pressing challenges in modern medicine.

• 34099-72-4(Hexadecanoic acid,(5-hydroxy-4-oxo-4H-pyran-2-yl)methyl ester)
• 6313-84-4((5-hydroxy-4-oxopyran-2-yl)methyl Nonanoate)
• 7248-78-4(&nbsp;)
• 532413-87-9(10-Undecenoic acid, (5-hydroxy-4-oxo-4H-pyran-2-yl)methyl ester)
• 67860-01-9(Maltyl butyrate)
• 62902-15-2(Decanedioic acid, bis[6-(hydroxymethyl)-4-oxo-4H-pyran-3-yl] ester)
• 94021-97-3(Butanoic acid,3-methyl-, 2-methyl-4-oxo-4H-pyran-3-yl ester)
• 26209-93-8(4H-Pyran-4-one,5-(acetyloxy)-2-[(acetyloxy)methyl]-)
• 93805-72-2(Butanoic acid,2-ethyl-4-oxo-4H-pyran-3-yl ester)
• 62902-16-3(Decanedioic acid, bis(2-methyl-4-oxo-4H-pyran-3-yl) ester)